Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
Ferric pyrophosphate is an iron replacement product used primarily to treat or prevent iron deficiency anemia, especially in patients with chronic kidney disease who are on hemodialysis. It works by providing bioavailable iron for erythropoiesis (red blood cell production), helping maintain hemoglobin levels. Ferric pyrophosphate forms a strong complex with the ligand, allowing efficient delivery of elemental iron into circulation and incorporation into hemoglobin. Its unique formulation allows for parenteral administration during dialysis sessions and is associated with fewer gastrointestinal side effects compared to some other oral or intravenous iron salts. In addition to medical use, it is also employed as a food fortificant and dietary supplement due to its high bioavailability and minimal impact on taste or color[1][2][6][9].
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Follow clinical development from study design and recruitment through results.
Explore development by indication, patient population, and geography.
Trace asset ownership, licensing agreements, and commercial partnerships.
Explore the patent landscape and regulatory exclusivity around an asset.
Compare development programs by target, modality, and indication.
Connect source evidence and development news to your research questions.
See how Gosset can support your research on ferric pyrophosphate.